anti-HHV-6 IgG – indirect immunofluorescence assay for the detection of IgG
antibodies to human herpesvirus type 6 (HHV-6).
Type d'échantillon
Serum
Attributs du produit
The kit is intended to the detection of IgG antibodies against HHV-6. The kit potentially can be
used for the detection of IgM antibodies, but it does not posses the positive control serum and the
corresponding FITC conjugate. The use of this kit is suitable for in vitro diagnosis of diseases
caused by or associated with HHV-6 infection. These include the diseases during childhood, such
as: exanthema subitum, acute respiratory diseases, febrile diarrheal illness and febrile convulsions;
or later in life: heterophilic antibody negative infectious mononucleosis.
HHV-6 can induce interstitial pneumonia, encephalitis, hepatitis and bone marrow depression in
immunodeficient patients
Ingrédients
Microscopic test slides coated with HHV6 infected cells, Positive control serum (lyophilized), Negative control serum (lyophilized), FITC-conjugated anti-human IgG antibody in buffer containing Evans blue as a counterstain (lyophilized), Mounting solution
Protocole
The surface of test slides is coated with T-lymphocyte cells that were infected with HHV-6in vitro.
Anti-HHV-6 antibodies, if present in the serum sample, bind to the virus antigens present within
the cells and on the cell membranes. Antibodies that do not bind to the antigens are washed away.
Those antibodies that formed complexes with the antigens are detected by FITC-labelled antihuman
antibodies (FITC conjugate). This FITC label is then visualized using a fluorescence
microscope.
Restrictions
For Research Use only
Stock
-20 °C
Stockage commentaire
The kit and its components should be stored in a dry and dark place at -18 to -28 °C.